These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 10854145)
1. Adenovirus p16 gene therapy for prostate cancer. Allay JA; Steiner MS; Zhang Y; Reed CP; Cockroft J; Lu Y World J Urol; 2000 Apr; 18(2):111-20. PubMed ID: 10854145 [TBL] [Abstract][Full Text] [Related]
2. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence. Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342 [TBL] [Abstract][Full Text] [Related]
3. p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma. Lee AW; Li JH; Shi W; Li A; Ng E; Liu TJ; Klamut HJ; Liu FF Mol Cancer Ther; 2003 Oct; 2(10):961-9. PubMed ID: 14578461 [TBL] [Abstract][Full Text] [Related]
4. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer. Eastham JA; Grafton W; Martin CM; Williams BJ J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161 [TBL] [Abstract][Full Text] [Related]
5. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Craig C; Kim M; Ohri E; Wersto R; Katayose D; Li Z; Choi YH; Mudahar B; Srivastava S; Seth P; Cowan K Oncogene; 1998 Jan; 16(2):265-72. PubMed ID: 9464545 [TBL] [Abstract][Full Text] [Related]
6. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas. Chi SG; deVere White RW; Muenzer JT; Gumerlock PH Clin Cancer Res; 1997 Oct; 3(10):1889-97. PubMed ID: 9815578 [TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells. Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762 [TBL] [Abstract][Full Text] [Related]
8. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways. Steiner MS; Wang Y; Zhang Y; Zhang X; Lu Y Oncogene; 2000 Mar; 19(10):1297-306. PubMed ID: 10713671 [TBL] [Abstract][Full Text] [Related]
9. [Effects of adenovirus-mediated p16 and p53 genes transfer on apoptosis and cell cycle of lung carcinoma cells]. Bai X; Che F; Li J; Ma Y; Zhou Y; Zhai J; Meng L Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):354-8. PubMed ID: 11866935 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Ghaneh P; Greenhalf W; Humphreys M; Wilson D; Zumstein L; Lemoine NR; Neoptolemos JP Gene Ther; 2001 Feb; 8(3):199-208. PubMed ID: 11313791 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer. Calbó J; Marotta M; Cascalló M; Roig JM; Gelpí JL; Fueyo J; Mazo A Cancer Gene Ther; 2001 Oct; 8(10):740-50. PubMed ID: 11687897 [TBL] [Abstract][Full Text] [Related]
12. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy. Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180 [TBL] [Abstract][Full Text] [Related]
13. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969 [TBL] [Abstract][Full Text] [Related]
14. Interaction between p53 and p16 expressed by adenoviral vectors in human malignant glioma cell lines. Kim SK; Wang KC; Cho BK; Chung HT; Kim YY; Lim SY; Lee CT; Kim HJ J Neurosurg; 2002 Jul; 97(1):143-50. PubMed ID: 12134905 [TBL] [Abstract][Full Text] [Related]
15. A recombinant adenovirus expressing p7(Kip1) induces cell cycle arrest and apoptosis in human 786-0 renal carcinoma cells. Katner AL; Gootam P; Hoang QB; Gnarra JR; Rayford W J Urol; 2002 Aug; 168(2):766-73. PubMed ID: 12131366 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibitory effect on glioma cells of adenovirus-mediated p16/INK4a gene transfer in vitro and in vivo. Lee SH; Kim MS; Kwon HC; Park IC; Park MJ; Lee CT; Kim YW; Kim CM; Hong SI Int J Mol Med; 2000 Nov; 6(5):559-63. PubMed ID: 11029524 [TBL] [Abstract][Full Text] [Related]
17. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839 [TBL] [Abstract][Full Text] [Related]
18. The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene. Patel SD; Tran AC; Ge Y; Moskalenko M; Tsui L; Banik G; Tom W; Scott M; Chen L; Van Roey M; Rivkin M; Mendez M; Gyuris J; McArthur JG Mol Ther; 2000 Aug; 2(2):161-9. PubMed ID: 10947944 [TBL] [Abstract][Full Text] [Related]
20. [Research on expression and control of p16 and p21 by wild-type p53 gene in two lung adenocarcinoma cell lines]. Jin Y; Yan CH; Wu Y; Liu Y; Zhang GY; Li P; Fu SB Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):409-12. PubMed ID: 14556194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]